Results summary | View all lists in GO:BiolProc | View all genes in C05AA.profile.ud50 |
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. enrichment: 1.91-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
214786_AT | MAP3K1 | G | X | P | S | mitogen-activated protein kinase kinase kinase 1 | |||||||
215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
217997_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
215990_S_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
209304_X_AT | GADD45B | G | D | X | S | growth arrest and DNA-damage-inducible, beta | |||||||
212593_S_AT | PDCD4 | G | R | programmed cell death 4 (neoplastic transformation inhibitor) | |||||||||
221009_S_AT | ANGPTL4 | G | D | X | E | S | angiopoietin-like 4 | ||||||
205409_AT | FOSL2 | R | FOS-like antigen 2 | ||||||||||
201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
37152_AT | PPARD | G | T | D | E | R | C | S | peroxisome proliferator-activated receptor delta | ||||
205067_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
209120_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
211833_S_AT | BAX | G | T | D | X | P | S | BCL2-associated X protein |